
Effect of booster dose on the prevalence of anti-SARS-CoV-2 antibodies among nursing home residents : brief communication on results of the SCOPE study : december 2021
(2021)
- Author
- Eline Meyers (UGent) , Ellen Deschepper (UGent) , Els Duysburgh, Liselore De Rop, Tine Deburghgraeve, Pauline Van Ngoc, Marina Di Gregorio, Simon Delogne, Anja Coen (UGent) , Nele De Clercq (UGent) , Laëtitia Buret, Samuel Coenen, An De Sutter (UGent) , Béatrice Scholtes, Jan Verbakel, Piet Cools (UGent) and Stefan Heytens (UGent)
- Organization
- Keywords
- Belgium, COVID-19, nursing homes, SARS-CoV-2, Seroprevalence
Downloads
-
published.pdf
- full text (Published version)
- |
- open access
- |
- |
- 327.24 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8738178
- MLA
- Meyers, Eline, et al. Effect of Booster Dose on the Prevalence of Anti-SARS-CoV-2 Antibodies among Nursing Home Residents : Brief Communication on Results of the SCOPE Study : December 2021. Sciensano, 2021.
- APA
- Meyers, E., Deschepper, E., Duysburgh, E., De Rop, L., Deburghgraeve, T., Van Ngoc, P., … Heytens, S. (2021). Effect of booster dose on the prevalence of anti-SARS-CoV-2 antibodies among nursing home residents : brief communication on results of the SCOPE study : december 2021. Brussels: Sciensano.
- Chicago author-date
- Meyers, Eline, Ellen Deschepper, Els Duysburgh, Liselore De Rop, Tine Deburghgraeve, Pauline Van Ngoc, Marina Di Gregorio, et al. 2021. “Effect of Booster Dose on the Prevalence of Anti-SARS-CoV-2 Antibodies among Nursing Home Residents : Brief Communication on Results of the SCOPE Study : December 2021.” Brussels: Sciensano.
- Chicago author-date (all authors)
- Meyers, Eline, Ellen Deschepper, Els Duysburgh, Liselore De Rop, Tine Deburghgraeve, Pauline Van Ngoc, Marina Di Gregorio, Simon Delogne, Anja Coen, Nele De Clercq, Laëtitia Buret, Samuel Coenen, An De Sutter, Béatrice Scholtes, Jan Verbakel, Piet Cools, and Stefan Heytens. 2021. “Effect of Booster Dose on the Prevalence of Anti-SARS-CoV-2 Antibodies among Nursing Home Residents : Brief Communication on Results of the SCOPE Study : December 2021.” Brussels: Sciensano.
- Vancouver
- 1.Meyers E, Deschepper E, Duysburgh E, De Rop L, Deburghgraeve T, Van Ngoc P, et al. Effect of booster dose on the prevalence of anti-SARS-CoV-2 antibodies among nursing home residents : brief communication on results of the SCOPE study : december 2021. Brussels: Sciensano; 2021.
- IEEE
- [1]E. Meyers et al., “Effect of booster dose on the prevalence of anti-SARS-CoV-2 antibodies among nursing home residents : brief communication on results of the SCOPE study : december 2021.” Sciensano, Brussels, 2021.
@misc{8738178, author = {{Meyers, Eline and Deschepper, Ellen and Duysburgh, Els and De Rop, Liselore and Deburghgraeve, Tine and Van Ngoc, Pauline and Di Gregorio, Marina and Delogne, Simon and Coen, Anja and De Clercq, Nele and Buret, Laëtitia and Coenen, Samuel and De Sutter, An and Scholtes, Béatrice and Verbakel, Jan and Cools, Piet and Heytens, Stefan}}, keywords = {{Belgium,COVID-19,nursing homes,SARS-CoV-2,Seroprevalence}}, language = {{eng}}, pages = {{4}}, publisher = {{Sciensano}}, title = {{Effect of booster dose on the prevalence of anti-SARS-CoV-2 antibodies among nursing home residents : brief communication on results of the SCOPE study : december 2021}}, year = {{2021}}, }